Dr. Abbey Reports on Latest Study Evaluating DME Outcomes After Switching from Faricimab-svoa to High-dose Aflibercept
In the latest issue of Ophthalmic Surgery, Lasers & Imaging Retina, Texas Retina’s Ashkan M. Abbey, MD, co-authored a retrospective study evaluating the effectiveness of high-dose aflibercept 8 mg (Eylea HD) in
read more
Dr. Abbey Presents ARCHER II Clinical Trial Data at The Retina Society Annual Scientific Meeting
Texas Retina’s Ashkan Abbey, MD, presented baseline characteristics of participants in the Phase 3 ARCHER II clinical trial for geographic atrophy (GA) secondary to dry age-related macular degeneration (AMD) at the 59th
read more Dr. Abbey Receives 2026 Achievement Award from the American Academy of Ophthalmology
Texas Retina’s Ashkan M. Abbey, MD, has earned the 2026 Achievement Award from the American Academy of Ophthalmology (AAO) in recognition of his contributions to the Academy, its scientific and educational programs,
read more Dr. Abbey Discusses the Use of VABYSMO® for Polypoidal Choroidal Vasculopathy
In the current issue of Ocular Surgery News on Healio, Texas Retina’s Ashkan M. Abbey, MD, shares his perspective on the recently reported two-year results from the Phase 3b/4 SALWEEN study evaluating
read more Dr. Abbey Participates in ReachMD CME on Sustained-Delivery TKIs for Wet AMD
Texas Retina’s Ashkan M. Abbey, MD, recently participated in a continuing medical education (CME) program through ReachMD, titled, “Redefining Durability in nAMD: The Science and Strategy of Sustained-Delivery TKIs.” During the program,
read more
Dr. Abbey Spoke About Vitrectomy and Light Adjustable Lenses at ASRS 2026
Texas Retina’s Ashkan Abbey, MD, FASRS, FAAO, participated in a panel discussion on the impact of vitrectomy on light adjustable lenses before final laser lock-in in post-cataract surgery patients at the 44th
read more Dr. Abbey Publishes Article on Home OCT Monitoring for Wet AMD
Texas Retina’s Ashkan M. Abbey, MD, recently published an article exploring how home optical coherence tomography (OCT) monitoring may help detect recurring disease activity earlier in patients with neovascular (wet) age-related macular
read more Dr. Abbey Shares Clinical Insights on Management of Wet AMD
Texas Retina’s Dr. Ashkan Abbey recently discussed neovascular (wet) age-related macular degeneration (AMD) management on Vumedi, a video education and peer-to-peer learning platform for doctors and medical professionals. Dr. Abbey’s video presentation
read more Dr. Abbey Discusses the New Era of Geographic Atrophy Management
Texas Retina’s Ashkan M. Abbey, MD, recently participated in a three-part special report video series by Ophthalmology Times that examined the evolving treatment landscape for geographic atrophy (GA). What is Geographic Atrophy?
read more Dr. Abbey Discusses Retinal Vein Occlusion as a Marker of Systemic Risk
Texas Retina’s Ashkan Abbey, MD, recently appeared on the ReachMD podcast to discuss “Retinal Vein Occlusion as a Marker of Systemic Risk.” This was the third episode he contributed to their “Eye
read more